Introduction
Primitive erythroid cells constitute a distinct lineage responsible for the first red blood cells circulating in the vertebrate embryo. Studies in the mouse indicate that this lineage emerges in the E7.5 -E9.0 yolk-sac as a transient wave of unipotential progenitors (EryP-CFC) (1) , that generates a cohort of primitive erythroblasts that mature semi-synchronously in the fetal circulation, ultimately enucleating between E12.5 -E16.5 to form primitive erythrocytes (2, 3) . While primitive erythropoiesis is short-lived, it is absolutely necessary for survival of the murine embryo, since Gata1-null mouse embryos die by E10.5, with specific failure to mature primitive erythroblasts beyond the proerythroblast stage (4) . Primitive erythropoiesis is superseded by definitive erythroid lineages that mature in the fetal liver (5) and begin to enter the bloodstream of the mouse embryo as erythrocytes between E11.5 -E12.5 (6) .
Signaling by erythropoietin (EPO), through its receptor EpoR, is necessary for the production of definitive erythrocytes in the murine fetal liver. Mice with targeted disruption of Epo or Epor die at E13.5 with a block in definitive erythropoiesis at the late progenitor (CFU-E) stage (7) (8) (9) . Consistent with these observations, EPO has been shown to critically regulate CFU-E survival in the adult (10) . Transgenic expression of EpoR in hematopoietic cells rescues the anemia and results in viable offspring, indicating that the erythroid effects of Epor deletion are responsible for fetal demise (11) .
The function of EPO in primitive erythropoiesis has remained controversial. Early studies indicated that addition of EPO to gastrulating mouse embryos failed to increase heme synthesis (12) . In contrast, EpoR transcripts were later detected during the initial emergence of primitive erythroid cells and exogenous EPO was demonstrated to increase embryonic globin gene expression in yolk sac explants (13) , suggesting that primitive erythroid cells are capable of responding to EPO. Additionally, while reduced numbers of primitive erythroblasts have been observed in Epor-null embryos (7) (8) (9) , their persistence has been widely interpreted to indicate that primitive erythropoiesis is independent of EpoR signaling (14) .
Here, we investigate the role of EPO in the emergence and maturation of the primitive erythroid lineage, making use of Epor-null mouse embryos and a novel primary primitive erythroid 2-step culture system. We find normal numbers of primitive erythroid progenitors are specified in the absence of Epor, while Epor-null embryos subsequently develop a progressive and profound anemia with a 90% loss of primitive erythroblasts by E12.5. Primitive erythroblasts deprived of EPO/EpoR have reduced rates of cell cycling and undergo apoptosis at late maturational stages. Surprisingly, Epor-null primitive erythroblasts that survive this genetic insult undergo accelerated cellular maturation. Furthermore, human primitive erythroblasts also exhibit increased cell death and an accelerated maturational state when cultured in the absence of EPO. Unlike the critical role for EPO/EpoR in definitive erythroid progenitor survival, we conclude that EPO signaling is not required for survival of the immature primitive erythroid progenitors but instead plays an evolutionarily conserved role to promote the proliferation, survival, and appropriate timing of terminal primitive erythroid precursor maturation.
Methods

Mice
Swiss Webster (Taconic, Germantown, NY) and Epor +/-mice (8) were mated overnight and vaginal plugs checked the following morning. Embryos from Epor +/-mouse matings were genotyped as described previously (8) . Erythroid cells per embryo were quantified using benzidine staining (15) .
EryP-CFC colony assays
EryP-CFC colonies were enumerated at 5 days of culture as described previously (1).
Alternatively, 0.2 ml benzidine dihydrochloride (Sigma, St Louis, MO) solution (2 mg/ml in 0.5% acetic acid, 0.15% H 2 O 2 ) was added to methylcellulose at 2 days and benzidine-positive cell clusters were enumerated.
Primitive erythroid 2-step culture
Cultures were initiated with trypsin-(Worthington Biochemical, Lakewood, NJ) dissociated E8.5 embryos on gelatin-coated wells (Corning Inc., Corning, NY, USA) for 24 hours in erythroid maturation media containing IMDM, 10% serum replacement (Invitrogen), 10% PFHM-II (Invitrogen), 2 mM glutamax, 150 μM MTG (Sigma), 1%
plasma-derived serum (Animal Technologies,Tyler, TX, USA), and 1 U/ml recombinant human EPO (Amgen, Thousand Oaks, CA, USA), unless otherwise noted. After 24
hours, non-adherent cells were transferred to uncoated wells and cultured for another 2-3 days (Fig S1) .
Imaging flow cytometry analysis of erythroid cell maturation
To analyze primitive erythroblast maturation, blood cells were stained with Hoechst Invitrogen) and cultured with or without EPO for the remainder of the culture period.
Baseline CFSE intensity was measured with a LSR-II flow cytometer 16 hours after staining and every day thereafter.
Apoptosis analysis
Primitive erythroblasts were stained and analyzed for apoptotic nuclear morphology using the ImageStream X as previously described (16, 17) .
Gene expression analysis
Quantitative real-time PCR (qPCR) was performed as described previously (18) . Primitive erythroblasts released from d8-10 embryoid bodies were transferred to erythroid differentiation media (as described above) and cultured for 6 days.
Results
EPO expression is preferentially localized to the embryo proper between E7.5-
E12.5 of mouse development
We previously detected EPO receptor (EpoR) expression within the yolk-sac blood islands beginning at E7.5 and increasing at E8.5 (13), i.e. during the emergence of the first primitive erythroid cells in the murine embryo. We recently utilized flow cytometry to sort comparatively staged primitive, fetal definitive, and adult definitive erythroid precursors to compare global gene expression by Affymetrix microarray (20) and found that primitive erythroblasts express increasing levels of EpoR transcripts as they mature between E9.5 -E12.5 ( Fig 1A) , suggesting that the cells respond to EPO.
Embryonic survival is dependent on EPO/EpoR and the identical phenotypes of Epoand Epor-null embryos indicate that maternal EPO, even when exogenously augmented, does not impact the fetus (7) (8) (9) , indicating that the murine embryo supplies its own EPO to ensure survival beyond E12.5. To determine the potential sources of EPO, we examined tissues from mouse embryos between E7.5 and E12.5 and found EPO transcripts localized almost exclusively in the embryo proper, increasing exponentially in the fetal liver by E10.5 ( Fig 1B) . The differential expression of EPO, consistent with previous findings (21) , indicates that EPO is produced in a spatially and temporally separate compartment from emerging primitive erythroid progenitors.
Epor is not necessary for specification of the primitive erythroid lineage
To determine if EPO/EpoR regulates the initial emergence of the primitive erythroid lineage, we analyzed the number of EryP-CFC in Epor-null mouse embryos at E8.5, a developmental time when EryP-CFC peak in number (1) . At day 5 (d5) of EryP-CFC culture, we found >80% loss of colony-forming ability in Epor-null embryos (Fig 2A) .
However, erythroid colony formation relies on the ability of progenitors to form erythroblast precursors that can proliferate and accumulate hemoglobin during their maturation. Therefore, a reduction in d5 EryP-CFC colonies could also be due to defective erythroid precursor maturation. To test this hypothesis, we quantified nascent EryP-CFC-derived colonies as benzidine-positive cell clusters consisting of ≥ 8 cells at d2 of culture (Fig 2A, B) . This analysis revealed near normal numbers of d2 EryP-CFC compared to wild-type littermates (Fig 2A) . Similarly, removal of EPO from the methylcellulose media resulted in an 80% decrease in the number of primitive erythroid colonies at d5, but only a marginal decrease in benzidine-positive cell clusters at d2 of culture ( Fig 2C) . Therefore, like the EPO-independent specification of CFU-E in the fetal liver (7), these data indicate that EpoR signaling is dispensable for specification of primitive erythroid progenitors in the mammalian embryo and suggest that EPO plays an important role in the subsequent maturation of primitive erythroid precursors.
Primitive erythroblast survival is dependent upon EpoR-mediated suppression of apoptosis at late stages of maturation
Primitive erythroid precursors normally undergo several maturational cell divisions between E9.5 and E12.5 as they transition from proerythroblasts to late-stage orthochromatic erythroblasts (1, 2). As previously described (7) (8) (9) , the number of primitive erythroblasts in Epor-null embryos was approximately half the normal number of primitive erythroblasts at E10.5 and only 10% of littermate controls at E12.5 ( Fig 3A) .
The etiology of this profound loss of maturing primitive erythroblasts has not been elucidated. Since EPO is known to provide antiapoptotic signals in definitive erythroid progenitors, we utilized imaging flow cytometry to identify erythroblasts displaying nuclear morphology associated with programmed cell death ( Fig S2) (16, 17) . At E10.5, the percentage of apoptotic primitive erythroblasts is 2-fold higher in Epor-null embryos compared to their wild-type littermates. However, by E11.5, more than 60% of the primitive erythroblasts in vivo are apoptotic in the absence of Epor (Fig 3B) . Consistent with these data, Bcl-xl expression is significantly reduced in primitive erythroblasts isolated from E11.5 Epor-null embryos (Fig 3C) , suggesting that Bcl-xl lies downstream of EpoR signaling and supports survival of late stage primitive erythroblasts.
To further explore the role of EPO during primitive erythroblast maturation, we developed a 2-step primitive erythroid culture assay ( Fig S1) . Consistent with in vivo expansion of the primitive erythron, EPO stimulation results in a robust expansion of benzidine-positive primitive erythroblasts during 4 days of in vitro culture ( Fig 3D) . EPO deprivation immediately following tissue dissociation and throughout the 4-day culture period reduced total erythroid output by 85% (Fig 3D) . Since EPO withdrawal in vitro recapitulates the kinetics of primitive erythroblast loss in Epor-null embryos, we investigated whether this loss was associated with increased apoptosis. Consistent with our observations of Epor-null embryos, EPO deprivation in wild-type primitive erythroblasts results in a greater than 2-fold increase in apoptosis, with a majority of cells succumbing at day 3 of culture ( Fig 3E) . To further characterize the anti-apoptotic response of primitive erythroblasts, we measured the expression of several genes known to influence erythroid cell survival (17, 22, 23 there is an increase in the expression of the pro-apoptotic genes Bax, Bid, and Bim upon EPO deprivation ( Fig 3F) . These data, taken together, provide evidence that EPO promotes primitive erythroblast survival during the terminal stages of erythroblast maturation by regulating the expression of pro-and anti-apoptotic genes.
Primitive erythroblast proliferation is dependent upon EPO/EpoR
To determine whether EPO also regulates the proliferation of maturing erythroblasts, we assessed the cell cycle status of viable primitive erythroblasts isolated from E10.5 embryos. Epor-null erythroblasts revealed a significant reduction in S-phase cells compared to wild-type littermates (Fig 4A,B) . Epor-null erythroblasts also exhibited a 2-fold increase in the percentage of cells in the G0/G1 and in the G2-M phases of the cell cycle (Fig 4A) . To further investigate how EPO regulates the proliferation of primitive erythroblasts, we utilized CFSE staining to track the number cell divisions in 2-step culture. Primitive erythroblasts deprived of EPO retain more CFSE than their EPOstimulated counterparts at d2 (Fig 4C, left panel) . By d3 of culture the difference in CFSE staining indicates that EPO stimulated primitive erythroblasts have undergone one more cell division than EPO-deprived erythroblasts (Fig 4C, right panel) . These data, taken together with cell cycle changes seen in vivo, indicate that EPO increases the proliferative capacity of maturing primitive erythroblasts, and provides another mechanism contributing to the progressive anemia that occurs in Epor-null embryos.
To characterize EPO-dependent transcriptional changes that may contribute to a reduction in primitive erythroblast cell cycling, we measured the expression of genes known to regulate the G1 to S phase transition. Interestingly, p21 expression, which has been shown to trigger cell cycle exit and terminal erythroid maturation in erythroleukemic and normal definitive erythroid cells (24), is not altered by EPO deprivation in primitive erythroid 2-step cultures (Fig 4D) . In contrast, EPO deprivation results in a 6-fold increase of p27 expression at d2 of culture compared to primitive erythroblasts stimulated by EPO (Fig 4D) . This induction of p27 is coincident with the reduction of primitive erythroblast proliferation in the absence of EPO and is consistent with the role of p27 in promoting cell cycle exit and terminal differentiation in definitive erythroid cells (25, 26) .
Primitive erythroblast maturation is accelerated in the absence of Epor
Primitive erythroblasts normally undergo semi-synchronous maturation characterized by reduced cell size, nuclear condensation, decreased RNA content, and organelle loss (2, 3). We utilized imaging flow cytometry to quantify these cellular features as primitive erythroblasts mature over developmental time (Fig 5A,B) . (Fig 5C,D) .
Primitive erythroblasts also undergo maturational changes at the molecular level.
We previously described a robust βH1-to εy-globin switch during primitive erythroblast maturation (18) . With EPO stimulation, wild-type primitive erythroblasts recapitulate the maturational globin switch in vitro, undergoing the transition of βH1-globin to εy-globin around day 3 of culture ( Fig 5E, left panel) . However, EPO-deprived primitive erythroblasts undergo the βH1-to εy-globin switch almost 1.5 days earlier (Fig 5E, right panel). Consistent with these results, we also find that the less robust ζ-to α-globin switch (18) has significantly progressed only in the cultures lacking EPO (Fig S3) .
Furthermore, E11.5 Epor-null erythroblasts stain more darkly with benzidine than those from wild-type littermates (Fig. 5F ), suggesting a higher concentration of hemoglobin.
These data, taken together, further support the concept that the lack of EPO leads to accelerated erythroid maturation.
EPO promotes survival of human primitive erythroblast survival and delays their maturation
Primitive erythroid cells constitute the first erythroid lineage in human embryos (27, 28) (Fig. 6A) . EPO deprivation prevented the expansion of hemoglobincontaining primitive erythroblasts (Fig 6B, blue line) and increased the proportion of apoptotic cells (Fig 6C) . In addition, EPO-deprived human primitive erythroblasts display evidence of advanced maturation compared to EPO-stimulated controls. Even by d2 of culture, EPO-deprived human primitive erythroblasts appear smaller with greater nuclear condensation than the EPO-stimulated cells and these differences remain evident up until d6, when primitive reticulocytes are formed (Fig 6A) . We used imaging flow cytometry to categorize primitive erythroblasts by their relative maturity based on cell and nuclear sizes as defined by the areas of CD235a and DAPI signal, respectively (Fig 6D) . By d3 of culture, the majority of human primitive erythroblasts stimulated with EPO were classified as "hEryP B" while the remaining cells were either less mature (hEryP A) or more mature (hEryP C). In the absence of EPO, nearly 80% of primitive erythroblasts were the most mature (hEryP C) cells with a complete absence of the least mature cohort of "hEryP A" cells (Fig 6E) .
Like the mouse, human primitive erythroblasts undergo ζ-to α-globin globin switching during maturation (31) . We asked whether this switch was accelerated in cultures of human erythroblasts deprived of EPO. As shown in Figure 6F , the relative proportion of ζ-globin expression was lower in EPO-deprived human primitive erythroblasts compared to EPO-stimulated cells. In addition, EPO-deprivation resulted in higher total α-globin transcript accumulation at d2 of culture, comparable to levels present in erythroblasts stimulated with EPO for 3 days (Fig 6F) . Taken together, these data support the concept that EPO regulates the rate of maturation of human primitive erythroblasts and suggests that this regulation is evolutionarily conserved in mammalian species.
Discussion
Both definitive and primitive erythropoiesis are characterized by colony-forming progenitor compartments that generate a wave of maturing erythroblast precursors.
Similar to BFU-E (7-10), we determined that EryP-CFC are specified independently of Epor. However, unlike CFU-E, EryP-CFC are not dependent on EPO for their survival.
Rather, our data indicate that EPO critically regulates the maturation of downstream primitive erythroblast precursors. These findings are consistent with the temporal and spatial expression of EPO, which has been shown previously to first take place in the vitelline vessel (21 However, cell surface expression of CD71 decreases between E10.5 and E11.5, suggesting that the maturational reduction of CD71 also occurs independent of its starting level. Changes in cell size, nuclear size and RNA content have been associated with apoptosis. To ensure that the changes we observed in primitive erythroblasts lacking EpoR were due to Epor ablation and not a secondary defect of apoptosis, we excluded morphologically apoptotic erythroblasts (16, 17) from this analysis.
Previously, we determined that a hallmark of primitive erythroblast maturation is a tightly controlled βH1-to εy-globin switch (18) . Removal of EPO induced an earlier transition of the β-globin maturational switch in our primitive erythroid 2-step culture compared to the EPO-stimulated cells. Furthermore, E11.5 primitive erythroblasts from
Epor-null embryos exhibited a higher ratio of εy-to βH1-globin expression compared to wild-type littermates (data not shown), consistent with an accelerated maturational state.
These changes in maturational state are associated with the reduced cell cycle progression and elevated expression of p27. Definitive erythroblast accumulation of p27 is associated with cell cycle exit during terminal maturation (25, 45) . The increase in p27
in EPO-deprived primitive erythroblasts may be responsible for the decrease in their proliferative capacity. Therefore, in addition to a providing a survival signal to primitive erythroblasts, EPO regulates the process of terminal erythroblast maturation, potentially by coordinating the timing of cell cycle exit.
Interestingly, mitochondrial loss during erythroblast maturation appears to be independent of EPO/EpoR, since primitive erythroblasts that are more mature based on smaller cell size, nuclear size, and lower RNA content retain mitochondria at levels comparable to a more immature state. This dysregulation raises an interesting question about the interplay of erythroblast maturation and the establishment of an anti-apoptotic intracellular milieu through EpoR signaling. Mitochondrial depolarization and subsequent cytochrome c release are critical steps in the initiation of apoptosis (46) .
The anti-apoptotic role of EPO/EpoR functions through the induction of Bcl-xl, which directly inhibits mitochondrial depolarization. Therefore, EpoR signaling may coordinate Bcl-xl induction at the appropriate cytoplasmic maturational state to ensure erythroblast survival. In the case of Epor-null primitive erythroblasts, Bcl-xl transcript levels are reduced and mitochondrial content is elevated relative to the apparent advanced maturational state of the cell, potentially further predisposing the mutant erythroblasts to apoptosis.
In order to examine whether human primitive erythroblasts respond to EPO like their murine counterparts, we generated immature primitive proerythroblasts from hES cells for further maturation in culture. We identified human primitive erythroblasts by cell morphology, ζ-globin gene expression and CD235a cell surface expression, and found that EPO promotes their survival and terminal maturation. Importantly, maturation of human primitive erythroblasts is accelerated in the absence of EPO stimulation, highlighting the analogous role of EPO in the mouse and human systems. To our knowledge, this is the first analysis of EPO function in human primitive erythroid cells.
Taken together, our data indicate that EpoR signaling is a critical regulator of multiple aspects of mammalian primitive erythropoiesis. While primitive erythroblasts are produced in the absence of EPO/EpoR, EpoR signaling is required for their optimal expansion by delaying cell cycle exit and terminal maturation, and by providing a critical survival signal to prevent apoptosis. These studies highlight the value of primitive erythropoiesis as a model system to investigate and better understand the regulation of terminal erythroid cell maturation. Given the many common attributes of primitive and definitive erythropoiesis, it will be of interest to determine if EPO functions analogously at late stages of definitive erythroblast maturation.
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